Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Income After Taxes 2010-2024 | MKKGY

Merck annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  • Merck income after taxes for the quarter ending September 30, 2024 was $0.893B, a 10.86% increase year-over-year.
  • Merck income after taxes for the twelve months ending September 30, 2024 was $2.938B, a 5.25% decline year-over-year.
  • Merck annual income after taxes for 2023 was $3.067B, a 12.81% decline from 2022.
  • Merck annual income after taxes for 2022 was $3.518B, a 2.98% decline from 2021.
  • Merck annual income after taxes for 2021 was $3.626B, a 59.28% increase from 2020.
  
Merck Annual Income After Taxes
(Millions of US $)
2023 $3,067
2022 $3,518
2021 $3,626
2020 $2,277
2019 $1,450
2018 $1,291
2017 $2,950
2016 $1,807
2015 $1,241
2014 $1,548
2013 $1,606
2012 $745
2011 $876
2010 $12,338
2009 $10,807
Merck Quarterly Income After Taxes
(Millions of US $)
2024-09-30 $893
2024-06-30 $652
2024-03-31 $759
2023-12-31 $634
2023-09-30 $805
2023-06-30 $770
2023-03-31 $858
2022-12-31 $667
2022-09-30 $933
2022-06-30 $926
2022-03-31 $992
2021-12-31 $923
2021-09-30 $901
2021-06-30 $900
2021-03-31 $902
2020-12-31 $510
2020-09-30 $943
2020-06-30 $318
2020-03-31 $505
2019-12-31 $374
2019-09-30 $377
2019-06-30 $473
2019-03-31 $226
2018-12-31 $204
2018-09-30 $376
2018-06-30 $291
2018-03-31 $420
2017-12-31 $1,165
2017-09-30 $763
2017-06-30 $465
2017-03-31 $557
2016-12-31 $285
2016-09-30 $513
2016-06-30 $355
2016-03-31 $654
2015-12-31 $130
2015-09-30 $407
2015-06-30 $382
2015-03-31 $322
2014-12-31 $349
2014-09-30 $331
2014-06-30 $420
2014-03-31 $449
2013-12-31 $384
2013-09-30 $454
2013-06-30 $413
2013-03-31 $355
2012-12-31 $3,646
2012-09-30 $236
2012-06-30 $-78
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $-121
2011-03-31 $3,505
2010-12-31 $6,575
2010-09-30 $277
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $18.255B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.873B 31.52
Zoetis (ZTS) United States $70.142B 26.46
Daiichi Sankyo, - (DSNKY) $43.872B 26.73
Takeda Pharmaceutical (TAK) Japan $43.719B 9.68
Sandoz Group AG (SDZNY) Switzerland $20.592B 0.00
Astellas Pharma (ALPMY) Japan $17.355B 12.30
United Therapeutics (UTHR) United States $17.000B 16.72
Summit Therapeutics (SMMT) United States $15.929B 0.00
Shionogi (SGIOY) Japan $12.267B 12.29
Neurocrine Biosciences (NBIX) United States $11.392B 34.73
Corcept Therapeutics (CORT) United States $7.704B 58.36
Madrigal Pharmaceuticals (MDGL) United States $7.495B 0.00
Orion OYJ (ORINY) Finland $7.424B 20.87
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.245B 0.00
Stevanato Group S.p.A (STVN) Italy $6.166B 39.92
Grifols, S.A (GRFS) Spain $5.074B 0.00
Ionis Pharmaceuticals (IONS) United States $5.023B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.650B 9.52
Recursion Pharmaceuticals (RXRX) United States $4.247B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.394B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.687B 12.18
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.432B 14.54
Hypermarcas (HYPMY) Brazil $2.185B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.098B 0.00
Soleno Therapeutics (SLNO) United States $2.047B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.945B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.766B 0.00
Evotec AG (EVO) Germany $1.566B 0.00
Ardelyx (ARDX) United States $1.506B 0.00
Indivior (INDV) United States $1.504B 6.13
Dyne Therapeutics (DYN) United States $1.406B 0.00
Guardian Pharmacy Services (GRDN) United States $1.323B 0.00
ARS Pharmaceuticals (SPRY) United States $1.166B 0.00
Ocular Therapeutix (OCUL) United States $1.160B 0.00
Xencor (XNCR) United States $1.134B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.127B 0.00
Harrow (HROW) United States $1.078B 0.00
Enliven Therapeutics (ELVN) United States $1.070B 0.00
Collegium Pharmaceutical (COLL) United States $0.965B 5.27
Bioventus (BVS) United States $0.838B 26.46
Avadel Pharmaceuticals (AVDL) Ireland $0.810B 0.00
Cronos Group (CRON) Canada $0.750B 0.00
Relay Therapeutics (RLAY) United States $0.696B 0.00
Verve Therapeutics (VERV) United States $0.683B 0.00
USANA Health Sciences (USNA) United States $0.595B 11.02
Xeris Biopharma Holdings (XERS) United States $0.592B 0.00
KalVista Pharmaceuticals (KALV) United States $0.529B 0.00
OmniAb (OABI) United States $0.518B 0.00
Elite Pharmaceuticals (ELTP) United States $0.509B 0.00
Altimmune (ALT) United States $0.482B 0.00
Savara (SVRA) United States $0.481B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.479B 0.00
ProKidney (PROK) United States $0.458B 0.00
Organogenesis (ORGO) United States $0.444B 0.00
Akebia Therapeutics (AKBA) United States $0.432B 0.00
Siga Technologies (SIGA) United States $0.431B 5.03
Zevra Therapeutics (ZVRA) United States $0.413B 0.00
Aldeyra Therapeutics (ALDX) United States $0.404B 0.00
Oruka Therapeutics (ORKA) United States $0.377B 0.00
Esperion Therapeutics (ESPR) United States $0.374B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.363B 147.29
Tourmaline Bio (TRML) United States $0.323B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.310B 0.00
CytoDyn (CYDY) United States $0.292B 0.00
Korro Bio (KRRO) United States $0.276B 0.00
Aquestive Therapeutics (AQST) United States $0.276B 0.00
Avita Medical (RCEL) United States $0.268B 0.00
Nature's Sunshine Products (NATR) United States $0.264B 15.71
Heron Therapeutics (HRTX) United States $0.257B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.241B 0.00
4D Molecular Therapeutics (FDMT) United States $0.219B 0.00
Inhibikase Therapeutics (IKT) United States $0.214B 0.00
Profound Medical (PROF) Canada $0.213B 0.00
Larimar Therapeutics (LRMR) United States $0.211B 0.00
MediWound (MDWD) Israel $0.199B 0.00
Nektar Therapeutics (NKTR) United States $0.184B 0.00
Lyell Immunopharma (LYEL) United States $0.181B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.177B 0.00
Nanobiotix S.A (NBTX) France $0.170B 0.00
Acrivon Therapeutics (ACRV) United States $0.165B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
VAXART, INC (VXRT) United States $0.165B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.150B 0.00
Silence Therapeutics (SLN) United Kingdom $0.150B 0.00
Champions Oncology (CSBR) United States $0.149B 0.00
Lexeo Therapeutics (LXEO) United States $0.147B 0.00
Cassava Sciences (SAVA) United States $0.134B 0.00
Inotiv (NOTV) United States $0.132B 0.00
ElectroCore (ECOR) United States $0.129B 0.00
Telomir Pharmaceuticals (TELO) United States $0.125B 0.00
Achieve Life Sciences (ACHV) Canada $0.110B 0.00
Journey Medical (DERM) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Metagenomi (MGX) United States $0.096B 0.00
Galectin Therapeutics (GALT) United States $0.095B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Regulus Therapeutics (RGLS) United States $0.085B 0.00
Protara Therapeutics (TARA) United States $0.082B 0.00
Pyxis Oncology (PYXS) United States $0.080B 0.00
Nutriband (NTRB) United States $0.080B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.08
Karyopharm Therapeutics (KPTI) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Mural Oncology (MURA) Ireland $0.073B 0.00
Avalo Therapeutics (AVTX) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Fractyl Health (GUTS) United States $0.070B 0.00
Century Therapeutics (IPSC) United States $0.064B 0.00
Gain Therapeutics (GANX) United States $0.064B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Unicycive Therapeutics (UNCY) United States $0.062B 0.00
AleAnna (ANNA) United States $0.062B 0.00
OptiNose (OPTN) United States $0.060B 0.00
FibroGen (FGEN) United States $0.057B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.056B 0.00
AlloVir (ALVR) United States $0.052B 0.00
Iterum Therapeutics (ITRM) Ireland $0.051B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
SCYNEXIS (SCYX) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
NRx Pharmaceuticals (NRXP) United States $0.040B 0.00
Surrozen (SRZN) United States $0.039B 0.00
CASI Pharmaceuticals (CASI) China $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
BioVie (BIVI) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Biomerica (BMRA) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
Mangoceuticals (MGRX) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
Ainos (AIMD) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.08
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00